Myriad Genetics Inc (MYGN)

Exchange
NASDAQ
Symbol
MYGN
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic Substances
Description
Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company is headquartered in Salt Lake City, Utah.
Country
USA

Stock price

At close: February 5, 2026

  • Open
    5.23
  • High
    5.37
  • Low
    5.03
  • Close
    5.10
  • Volume
    1,231,940

Financial ratios

Dec 31, 2024